Clinical research studyMining Retrospective Data for Virtual Prospective Drug Repurposing: L-DOPA and Age-related Macular Degeneration
Keywords
Cited by (0)
Funding: This project was partially supported by National Institutes of Health (NIH) grants UL1TR000427 and 1U01HG006389-01, The Wisconsin Genome Initiative and the Marshfield Clinic (Marshfield Clinic); P30EY001931, UL1TR000055, The Edward N. & Della L. Thome Memorial Foundation, (Medical College of Wisconsin); NIH Center Core Grant P30EY014801 (Bascom Palmer Eye Institute); BrightFocus Foundation and unrestricted grants from Research to Prevent Blindness to the University of Arizona and Bascom Palmer Eye Institute.
Conflict of Interest: BSM is an inventor on an approved patent for the use of L-DOPA to treat or delay age-related macular degeneration, and has received no income from this patent.
Authorship: All authors participated and approved this submission.